<?xml version='1.0' encoding='utf-8'?>
<document id="29721322"><sentence text="Direct and cytokine-mediated effects of albumin-fused growth hormone, TV-1106, on CYP enzyme expression in human hepatocytes in vitro." /><sentence text="Some biologics can modulate cytokines that may lead to changes in expression of drug-metabolizing enzymes and cause drug-drug interactions (DDI)" /><sentence text=" DDI potential of TV-1106-an albumin-fused growth hormone (GH)-was investigated" /><sentence text=" In this study, human blood was exposed to recombinant human growth hormone (rhGH) or TV-1106, followed by isolation of the plasma and its application to human hepatocytes" /><sentence text=" While the treatment of blood with rhGH increased multiple cytokines, treatment of blood with TV-1106 had no effect on any of the nine cytokines tested" /><sentence text=" The interleukin (IL)-6 concentration was higher in the rhGH then in the TV-1106-treated plasma (P &lt; " /><sentence text="05)" /><sentence text=" While rhGH had little or no effect on CYP1A2 or CYP2C19 mRNA but increased CYP3A4 mRNA twofold, TV-1106 had little or no effect on cytochrome P450 (CYP) mRNAs in hepatocytes" /><sentence text=" Although the plasma from rhGH-treated blood lowered CYP1A2 activity, the TV-1106 plasma had no effect on CYP activities" /><sentence text=" The CYP1A2 activity was lower in the rhGH- then in the TV-1106-plasma treated hepatocytes (P &lt; " /><sentence text="05)" /><sentence text=" The results indicated that fusing GH with albumin made TV-1106 an unlikely participant of CYP1A2, CYP2C19 or CYP3A4-facilitated, direct or cytokine-driven DDI" /><sentence text="" /></document>